Please use this identifier to cite or link to this item: http://hdl.handle.net/10201/21452

Title: Interleukin-7 (IL-7) and IL-7 receptor (IL-7R) signalling complex in human solid tumours
Issue Date: 2003
Publisher: Murcia : F. Hernández
ISSN: 0213-3911
Related subjects: CDU::6 - Ciencias aplicadas::61 - Medicina::616 - Patología. Medicina clínica. Oncología
Keywords: Lymphangiogenesis
Breast cancer
Abstract: Interleukin-7 (IL-7) plays an important role in the normal development and maintenance of the human immune system. Its effects are mediated via its receptor, IL-7R. Ligand-receptor engagement results in a cascade of phosphorylation events mediated by various molecules including the Janus kinases (Jak1 and Jak3), PI3-kinase, Stats (signal transducers and activators of transcription) and other molecules. The activation of IL- 7 signalling pathway results in survival, proliferation, differentiation and maturation of haematopoietic cells including B and T lymphocytes. Although the relationship of IL-7 with the development and differentiation of some haematological cancers like leukaemias and lymphomas is well recognised, little is known about it involvement with solid tumours. There are several studies that have revealed IL-7/IL-7R expression in epithelial systems and some human solid epithelial tumours. Furthermore, IL-7 can be produced by some human tumour cells and involved in tumour development and progression. In this review article we have summarised the main biological activities of IL-7 and its downstream signalling complex in relation to some human solid malignancies.
Primary author: Al-Rawi, M.A.A.
Mansel, R.E.
Jiang, W.G.
Published in: Histology and histopathology
URI: http://hdl.handle.net/10201/21452
Document type: info:eu-repo/semantics/article
Number of pages / Extensions: 13
Rights: info:eu-repo/semantics/openAccess
Appears in Collections:Vol.18, nº 3 (2003)

Files in This Item:
File Description SizeFormat 
Interleukin7 IL7 and IL7 receptor IL7R.pdf386,92 kBAdobe PDFView/Open


Items in Digitum are protected by copyright, with all rights reserved, unless otherwise indicated.